1,351
Participants
Start Date
December 31, 2008
Primary Completion Date
January 31, 2010
Study Completion Date
June 30, 2010
Fondaparinux sodium
After randomization (Day 1), subjects will receive subcutaneously once daily fondaparinux 2.5 mg \[0.5mL\] (1.5 mg \[0.3mL\] in patients with creatinine clearance between 30 and 50 mL/min) for at least 21 Days, up to complete mobilization, corresponding to cast or brace removal. The maximal duration of treatment is 45 days.
Nadroparin
After randomization (Day 1), subjects will receive subcutaneously once daily nadroparin 2850 anti-Xa IU (0.3 mL) for at least 21 Days, up to complete mobilization, corresponding to cast or brace removal. The maximal duration of treatment is 45 days.
GSK Investigational Site, Orbassano (TO)
GSK Investigational Site, Berlin
GSK Investigational Site, Castellon
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Córdoba
GSK Investigational Site, Pozoblanco/Córdoba
GSK Investigational Site, A Coruña
GSK Investigational Site, Ferrol. La Coruña
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Genoa
GSK Investigational Site, Saintes
GSK Investigational Site, Milan
GSK Investigational Site, Hamburg
GSK Investigational Site, Mondragón - Guipúzcoa
GSK Investigational Site, Hamburg
GSK Investigational Site, Jaén
GSK Investigational Site, Lübeck
GSK Investigational Site, Linares
GSK Investigational Site, Bergamo
GSK Investigational Site, Lugo
GSK Investigational Site, Madrid
GSK Investigational Site, Aravaca
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Majadahonda/Madrid
GSK Investigational Site, Torrelodones/Madrid
GSK Investigational Site, Valdemoro/Madrid
GSK Investigational Site, Getafe/Madrid
GSK Investigational Site, Brest
GSK Investigational Site, Hanover
GSK Investigational Site, Conegliano (TV)
GSK Investigational Site, Toulouse
GSK Investigational Site, Ourense
GSK Investigational Site, Udine
GSK Investigational Site, Avilés/Asturias
GSK Investigational Site, Rennes
GSK Investigational Site, Padua
GSK Investigational Site, Vigo/Pontevedra
GSK Investigational Site, Grenoble
GSK Investigational Site, Zerbst
GSK Investigational Site, Bologna
GSK Investigational Site, Seville
GSK Investigational Site, Roanne
GSK Investigational Site, Nantes
GSK Investigational Site, Moers
GSK Investigational Site, Agen
GSK Investigational Site, Angers
GSK Investigational Site, Siena
GSK Investigational Site, Gevelsberg
GSK Investigational Site, Lille
GSK Investigational Site, Valenciennes
GSK Investigational Site, Beauvais
GSK Investigational Site, Clermont-Ferrand
GSK Investigational Site, Orthez
GSK Investigational Site, Wiesbaden
GSK Investigational Site, Colmar
GSK Investigational Site, Heidelberg
GSK Investigational Site, Lyon
GSK Investigational Site, Lyon
GSK Investigational Site, Lyon
GSK Investigational Site, Sainte Colombe Les Vienne
GSK Investigational Site, Pringy
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Rouen
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Erlangen
GSK Investigational Site, Antony
GSK Investigational Site, Bobigny
GSK Investigational Site, Créteil
GSK Investigational Site, Argenteuil
GSK Investigational Site, Catania
GSK Investigational Site, Cergy-Pontoise
GSK Investigational Site, Saint-Pierre
GSK Investigational Site, Moscow
GSK Investigational Site, Yaroslavl
GSK Investigational Site, Yaroslavl
GSK Investigational Site, Tver'
GSK Investigational Site, Saint Petersburgh
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Kursk
GSK Investigational Site, Palencia
GSK Investigational Site, Stavropol
GSK Investigational Site, Ryazan
GSK Investigational Site, Samara
GSK Investigational Site, Samara
GSK Investigational Site, Ufa
GSK Investigational Site, Perm
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Tyumen
GSK Investigational Site, Novosibirsk
GSK Investigational Site, Tomsk
GSK Investigational Site, Kemerovo
GSK Investigational Site, Barnaul
GSK Investigational Site, Irkutsk
GSK Investigational Site, Mougins
GSK Investigational Site, Dresden
GSK Investigational Site, Dresden
GSK Investigational Site, Schmiedeberg
GSK Investigational Site, Zwickau
GSK Investigational Site, Altenburg
GSK Investigational Site, Latina
GSK Investigational Site, Rome
GSK Investigational Site, Amersfoort
GSK Investigational Site, Eindhoven
GSK Investigational Site, Maastricht
GSK Investigational Site, Sittard-geleen
GSK Investigational Site, Utrecht
GSK Investigational Site, Venlo
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Don Benito/Badajoz
GSK Investigational Site, Palma de Mallorca
GSK Investigational Site, San Sebastián de Los Reyes/Madrid
GSK Investigational Site, Torrevieja
Lead Sponsor
GlaxoSmithKline
INDUSTRY